Articles related to RISK ASSESSMENT

Clinical evidence shows that as people age, their bodies become less efficient at clearing cholesterol from the bloodstream, necessitating more aggressive monitoring and management strategies.

Large-scale analysis of 5.1 million individuals reveals distinct correlations between blood types and 49 different diseases, offering new perspectives for risk assessment in clinical practice.

Clinical research demonstrates that erythritol consumption increases blood levels by more than 1,000 times and enhances platelet responsiveness in healthy volunteers, potentially elevating cardiovascular risk in susceptible populations.

“Doctors must make difficult judgment calls to protect patients, even if it yields an unwanted outcome,” says attorney Denzell Moton, highlighting the complex nature of medical decision-making in critical situations.

Bempedoic acid reduced major adverse cardiovascular events by 13% compared to placebo in statin-intolerant patients, with efficacy comparable to statins when normalized for LDL-C reduction.

The 2024 guideline introduces a more nuanced approach to preoperative stress testing and anticoagulation management, potentially reducing unnecessary testing and complications.